Elevar Therapeutics files an NDA for lirafugratinib as a second-line treatment for patients with cholangiocarcinoma whose tumors harbor FGFR2 fusions ...
Sen. Rick Scott (R-FL) introduces legislation that would require prescription drug labels in the U.S. to disclose where drugs and their active pharmac...
FDA approves Tenpoint Therapeutics Yuvezzi as the only combination eye drop approved to treat presbyopia in adults.
FDA posts an updated guidance clarifying when clinical decision support software functions fall outside the definition of a regulated medical device.
An industry consultant says reduced FDA staffing levels and high turnover are extending regulatory timelines and forcing drug developers to invest mor...
Axios reports that the vice chair of the CDC Advisory Committee on Immunization Practices says the Pfizer and Moderna Covid mRNA vaccines should be re...
CDRH reports on its 2025 MDUFA 5 activities to promote international harmonization.
A Congressional Research Service backgrounder explains options Congress could consider to resolve some issues with the skinny label provision in the W...
